首页 Home文章正文

octagonpokertable| Synthetic biology concept attracts much attention, Rhein Biotech accelerates the layout of the track

Home 2024年05月08日 20:00 6 editor

The concept of synthetic biology has been popular recently, and related enterprises have become the focus of investors. As a leader in the domestic plant extraction industry, the layout and future planning of Rhine Biological (Rights Protection) (002166) in the field of synthetic biotechnology has attracted much attention.

RWE said on the interactive platform on May 7 that at this stage, the company has obtained a number of patents on a number of biosynthetic products and obtained some brand-new structural products. After the company's synthesis workshop is completed and put into production, the related products will be produced on a large scale. It is expected to be put on the market in 2024 and enhance the service capacity of the company's application solutions.

In the secondary market, on May 8, synthetic biological concept stocks continued to be active. As of the close, Rhine Biological, Lukang Medicine and Azure Biological rose by the daily limit, while Smith Barney Technology closed up 10%.Octagonpokertable.64%, Ojai Pharmaceuticals rose by more than 15%. The concept of synthetic biology has been hot since April, with the Wind synthetic biology index rising 26% in the 10 trading days since April 22.

octagonpokertable| Synthetic biology concept attracts much attention, Rhein Biotech accelerates the layout of the track

The so-called "synthetic biology" is a brand-new "creation" technology. Huaan Securities pointed out that the technology is integrated.OctagonpokertableA variety of technologies, such as biology, chemistry, engineering and so on, are used to obtain target products by large-scale fermentation using renewable biomass as raw materials and organisms as production media, using cheap raw materials and bacteria, cells and enzymes as manufacturing plants. It has the characteristics of clean, efficient and renewable.

According to the annual report, Rhine Biology is the first listed company in the domestic plant extraction industry, specializing in the new "Little Giant" enterprise. Rhine Biology is mainly engaged in the production and operation of natural health products, focusing on the research and extraction of plant functional components.

At the performance presentation meeting held on April 29, RWE said that its synthetic biotechnology research and development project mainly focused on natural sweeteners, polysaccharides, peptides and other products, such as enzyme conversion of rare components of stevioside has entered a pilot test, the R & D project of biopolysaccharides and peptides is currently in the patent application stage, and the synthetic biology workshop has entered a relatively late stage and is expected to be put into use in the third quarter. In the future, RWE's investment in synthetic biological business will focus on the R & D and commercial application of scarce or high value-added natural ingredients.

In addition, the cooperation between RWE and DSM Meiyi has further deepened the company's layout in the field of synthetic biology. The two sides agreed to jointly build a technical team to strengthen the research and development of formula applications, in order to better develop and serve domestic customers. DSM's strong R & D strength and numerous patents in the field of synthetic biology provide more possibilities for RWE's cooperation in this field.

Western Securities pointed out that synthetic biology is still in the early stage of industrialization, and Chinese enterprises are expected to become globally competitive enterprises by virtue of synthetic biological products and cost advantages. It is suggested to pay attention to the subdivision direction with leading cost or high added value of products and strong industrialization strength. At the same time, Huaan Securities said through the latest research report that biological manufacturing is the key development direction of biological economy, and the industrialization of biological manufacturing is expected to speed up under the background of frequent policy landing.

相关文章

slots deposit bonus